- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.16: 1 residues within 4Å:- Chain M: N.590
Ligand excluded by PLIPNAG.17: 1 residues within 4Å:- Chain M: N.603
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain M: H.642, V.643, N.644
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain M: N.696, G.1118
- Chain O: D.783
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain M: A.693, E.1059, N.1061
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain N: N.48
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain N: N.590, T.591
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain N: N.603
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain N: H.642, V.643, N.644
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain M: D.783
- Chain N: N.696, G.1118
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain N: A.693, E.1059, N.1061
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain O: N.590, T.591
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain O: N.603
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain O: H.642, V.643, N.644
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain N: D.783
- Chain O: N.696, G.1118
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain O: A.693, E.1059, N.1061
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, N. et al., Structure-based development of human antibody cocktails against SARS-CoV-2. Cell Res. (2021)
- Release Date
- 2020-12-16
- Peptides
- Heavy Chain of FC05 Fab: AIK
Light Chain of FC05 Fab: BJL
Light Chain of H014 Fab: CEG
Heavy Chain of H014 Fab: DFH
Spike glycoprotein: MNO - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
LI
NK
PB
CJ
KL
MC
DE
FG
HD
EF
GH
IM
ON
QO
R
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, N. et al., Structure-based development of human antibody cocktails against SARS-CoV-2. Cell Res. (2021)
- Release Date
- 2020-12-16
- Peptides
- Heavy Chain of FC05 Fab: AIK
Light Chain of FC05 Fab: BJL
Light Chain of H014 Fab: CEG
Heavy Chain of H014 Fab: DFH
Spike glycoprotein: MNO - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
LI
NK
PB
CJ
KL
MC
DE
FG
HD
EF
GH
IM
ON
QO
R